 NEW YORK, March 15, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GenMark Diagnostics, Inc. GenMark or the Company NASDAQ: GNMK in connection with the proposed acquisition of the Company by Roche Holdings, Inc., a global pioneer in pharmaceuticals and diagnostics. The transaction is structured as an all-cash tender offer in which the Companys shareholders will receive 24.05 for each share of GenMark that they hold. 